1016506-18-5

Basic information

• Product Name: Carbamic acid, N-[4-amino-3-(trifluoromethyl)phenyl]-, 1,1-dimethylethyl ester
• CAS NO: 1016506-18-5
• Molecular Weight: 276.259
• Mol File: 1016506-18-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Carbamic acid, N-[4-amino-3-(trifluoromethyl)phenyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, N-[4-amino-3-(trifluoromethyl)phenyl]-, 1,1-dimethylethyl ester(1016506-18-5)
• EPA Substance Registry System: Carbamic acid, N-[4-amino-3-(trifluoromethyl)phenyl]-, 1,1-dimethylethyl ester(1016506-18-5)

Safety Data

• Hazardous Substances Data: 1016506-18-5(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 121-01-7 4-nitro-2-trifluoromethyl-aniline 
• 1043962-44-2 tert-butyl (4-nitro-2-trifluoromethylphenyl)carbamate 
• 1043962-48-6 tert-butyl N-[4-nitro-3-(trifluoromethyl)phenyl]carbamate 
• 393-11-3 4-nitro-3-(trifluoromethyl)benzeneamine 

Relevant articles and documents

DIAMINE COMPOUND AND METHOD FOR PRODUCING SAME

The present invention provides a novel diamine compound capable of producing a polymer which exhibits greatly enhanced mechanical properties and heat resistance while maintaining transparency. A film including a polymer produced using the diamine compound has excellent transparency, heat resistance, mechanical strength and flexibility, and thus can be used in various fields, such as in a device substrate, a display cover substrate, an optical film, an Integrated circuit (IC) package, an adhesive film, a multi-layer flexible printed circuit (FPC), a tape, a touch panel and an optical disc protection film, and the like.

COMPOUNDS USEFUL AS CSF1 MODULATORS

This invention relates to novel compounds and to pharmaceutical compositions comprising the novel compounds. More specifically, the invention relates to compounds useful as Colony Stimulating Factor 1 Receptor (cFMS) modulators (e.g. cFMS inhibitors). This invention also relates to processes for preparing the compounds, uses of the compounds in treatment and methods of treatment employing the compounds. Specifically, the invention relates to the use of the compounds for the treatment of cancer and autoimmune diseases.